1. Home
  2. NRSN vs TPIC Comparison

NRSN vs TPIC Comparison

Compare NRSN & TPIC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NRSN
  • TPIC
  • Stock Information
  • Founded
  • NRSN 2017
  • TPIC 1968
  • Country
  • NRSN Israel
  • TPIC United States
  • Employees
  • NRSN N/A
  • TPIC N/A
  • Industry
  • NRSN Biotechnology: Pharmaceutical Preparations
  • TPIC Industrial Machinery/Components
  • Sector
  • NRSN Health Care
  • TPIC Industrials
  • Exchange
  • NRSN Nasdaq
  • TPIC Nasdaq
  • Market Cap
  • NRSN 37.9M
  • TPIC 35.5M
  • IPO Year
  • NRSN 2021
  • TPIC 2016
  • Fundamental
  • Price
  • NRSN $1.79
  • TPIC $1.30
  • Analyst Decision
  • NRSN Buy
  • TPIC Hold
  • Analyst Count
  • NRSN 2
  • TPIC 6
  • Target Price
  • NRSN $14.00
  • TPIC $1.82
  • AVG Volume (30 Days)
  • NRSN 297.9K
  • TPIC 529.1K
  • Earning Date
  • NRSN 06-23-2025
  • TPIC 05-12-2025
  • Dividend Yield
  • NRSN N/A
  • TPIC N/A
  • EPS Growth
  • NRSN N/A
  • TPIC N/A
  • EPS
  • NRSN N/A
  • TPIC N/A
  • Revenue
  • NRSN N/A
  • TPIC $1,373,242,000.00
  • Revenue This Year
  • NRSN N/A
  • TPIC $10.66
  • Revenue Next Year
  • NRSN N/A
  • TPIC $6.52
  • P/E Ratio
  • NRSN N/A
  • TPIC N/A
  • Revenue Growth
  • NRSN N/A
  • TPIC 3.05
  • 52 Week Low
  • NRSN $0.51
  • TPIC $0.64
  • 52 Week High
  • NRSN $1.80
  • TPIC $5.64
  • Technical
  • Relative Strength Index (RSI)
  • NRSN 73.77
  • TPIC 60.83
  • Support Level
  • NRSN $1.65
  • TPIC $1.21
  • Resistance Level
  • NRSN $1.77
  • TPIC $1.38
  • Average True Range (ATR)
  • NRSN 0.14
  • TPIC 0.13
  • MACD
  • NRSN 0.02
  • TPIC 0.00
  • Stochastic Oscillator
  • NRSN 100.00
  • TPIC 75.00

About NRSN NeuroSense Therapeutics Ltd.

NeuroSense Therapeutics Ltd is a clinical-stage biotechnology company focused on discovering and developing treatments for patients suffering from debilitating neurodegenerative diseases. These diseases include Amyotrophic Lateral Sclerosis, or ALS, Alzheimer's disease, and Parkinson's disease, among others. Its product candidate, PrimeC, is a novel extended-release or ER, oral formulation of a fixed dose combination of two generic FDA-approved drugs, ciprofloxacin and celecoxib, combined in a specific ratio.

About TPIC TPI Composites Inc.

TPI Composites Inc is engaged in manufacturing composite wind blades. The company operates in wind energy and transportation industries where it manufactures structures for a bus, rail, theme parks, and trucks. Geographically the segments are divided into the U.S, Asia, Mexico, EMEA and India where the Mexico segment derives a majority of revenue.

Share on Social Networks: